Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Our compounded weight loss medication uses the same active ingredients in different doses as a non-brand name compounded version
Hanmi, Sanfer Partner to Bring GLP-1 Therapy to Mexico Hanmi Pharmaceutical has signed an exclusive distribution agreement with Mexico-based Laboratorios Sanfer to introduce efpeglenatide, a GLP-1 therapy for obesity, alongside Hanmis Dapalon Family diabetes treatments, marking a step in the South Korean companys global expansion strategy focused on metabolic diseases
We could not check the others because we were never told who they are
These include additional focus on social determinants of health, the healthcare system and physical activity behaviours including sleep
